ArticleEye and vision (London, England)2026
Outcomes of modified pneumatic retinopexy with transscleral subretinal fluid drainage for primary rhegmatogenous retinal detachment.
Article in Eye and vision (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary rhegmatogenous retinal detachment (RRD) occurs when a retinal tear or break causes fluid from inside the eye to seep behind the retina, which pushes it away from the wall of the eye. This can cause permanent vision loss if not treated. Which of three current interventions is optimal to treat RRD has not been established. We evaluated the anatomical and visual outcomes of a modified pneumatic retinopexy (mPnR) that drains fluid from beneath the retina to treat RRD.
methodsThis retrospective single-center case series included 53 consecutive eyes of 53 patients with primary RRD who met the pneumatic retinopexy versus vitrectomy trial criteria. All patients underwent mPnR that comprised transscleral subretinal fluid drainage, intravitreal air injection, and postoperative laser photocoagulation of retinal breaks. The main outcome measures were single-surgery anatomical success rates and best-corrected visual acuity (BCVA) at 3 months postoperatively.
resultsThe single-surgery anatomical success rate was 51 of 53 (96.23%). Three months postoperatively, the median BCVA had significantly improved from a preoperative logarithm of the minimum angle of resolution (logMAR) of 0.10 (interquartile range [IQR], 0.00-0.60) to 0.02 (IQR, 0.00-0.20) (P < 0.001). The anatomic success rate was 100% for the macula-off subgroup (n = 20), as BCVA improved from 0.75 (IQR, 0.43-1.18) to 0.20 (IQR, 0.04-0.30) logMAR (P < 0.001). Two eyes (3.77%) with recurrent detachment and one eye (1.89%) with a secondary macular epiretinal membrane required subsequent pars plana vitrectomy.
conclusionsThe mPnR procedure is efficient and minimally invasive, expansile gas is not required, and preliminary safety and efficacy profiles were favorable. Therefore, mPnR offers a simplified, feasible surgical option for treating eligible patients with primary RRD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.